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Urate oxidase is an important enzyme with therapeutic and diagnostic applications. Rasburicase is a recombinant
urate oxidase enzyme approved by FDA to use in the treatment of hyperuricemia conditions. Various hosts such as
Saccharomyces cerevisiae, Hansenula polymorpha and Escherichia coli have been used to express the enzyme. Today,
Pichia pastoris is considered as an important host for heterologous protein expression since it has beneficial
characteristics such as strong promoters, simple scale up, post translational modifications, high cell density
cultivation and simple genetic manipulation. In this study, Aspergillus flavus urate oxidase gene was cloned in
pPICZαA expression vector and expressed in P. pastoris. The recombinant urate oxidase was expressed in secretory
form and was confirmed through RT-PCR, SDS-PAGE analysis and western blotting. The enzyme activity was
determined using a colorimetric assay. A production yield of 0.43 U/ml of culture supernatant was obtained.
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Urate oxidase (EC 1.7.3.3) plays an important role in
purine degradation pathway and catalyzes uric acid oxi-
dation into allantoin, H2O2 and CO2 in the presence of
oxygen (Collings et al. 2010). The Aspergillus flavus
urate oxidase (135 kDa) contains four identical subunits,
in which each subunit is associated with one active site.
Urate oxidase is a non-glycosylated enzyme having no
intra- or inter-disulfide bonds with a blocking acetyl
group located at the N-terminal (Legoux et al. 1992).
Urate oxidase is not expressed in human and other
higher primates. Although active urate oxidase is de-
tected in some kinds of Old World monkeys, but it is
much less active in comparison to urate oxidase in mice
and rabbits (Alvarez-Lario and Macarron-Vicente 2010).
Although Uric acid is considered to donate more than
half the antioxidant capacity of blood resulting in dimin-
ution of age-specific cancer and enhancement of life ex-
pectancy, but hyperuricemia due to tumor lysis syndrome,
excessive dietary purine intake and genetic basis leads to* Correspondence: v_khalaj@yahoo.com
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in any medium, provided the original work is pincreased risk of hypertension, coronary heart disease,
renal dysfunction and gout (Garay et al. 2012).
Since urate oxidase converts uric acid to a more soluble
compound, allantoin, it promotes allantoin excretion and
prevents uric acid accumulation. Therapeutic effects of
urate oxidase by intravenous administration was reported
by London and Hudson in 1957 and Rasburicase, a re-
combinant urate oxidase, was approved after 44 years for
treating severe hyperuricemia in patients receiving chemo-
therapy in Europe and US (Kennedy and Ajiboye 2010).
The urate oxidase of various fungal and non-fungal
organisms have been cloned and expressed in different
prokaryotic and eukaryotic systems including E. coli,
Saccharomyces cerevisiae and Hansenula polymorpha.
Rasburicase (Fasturtec) is a recombinant Aspergillus flavus
urate oxidase, consisting of 301 amino acids, expressed in
S. cerevisiae. The capability of rasburicase in the reduction
of blood uric acid levels and prevention of urate crystals
formation in patients is asserted by some surveys (Bosly
et al. 2003; Cammalleri and Malaguarnera 2007; Kennedy
and Ajiboye 2010).
Pichia pastoris is known as a high expressing host
(Hsu et al. 2009). Due to the strong methanol-induced
alcohol oxidase1 (AOX1) promoter, the small amounts
of extra cellular proteins and proteases, the formation ofOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Fazel et al. SpringerPlus 2014, 3:395 Page 2 of 7
http://www.springerplus.com/content/3/1/395high-copy number integrants and the possibility to select
high-copy number colonies by Zeocin™ increasing con-
centrations, this organism is considered as a highly com-
petitive host for the production of urate oxidase (Arakawa
et al. 2006; Daly and Hearn 2005). The first drug produced
in P. pastoris (Kalbitor) was approved by FDA in 2009 and
some other pharmaceuticals including human recom-
binant serum albumin, hepatitis B vaccine, Botulinum
vaccine, Interferon alpha and recombinant human insulin
are commercialized (http://pichia.com/science-center/
commercialized-products/).
In this study, the A. flavus urate oxidase gene was codon
optimized according to the codon usage of P. pastoris and
synthesized commercially. The synthetic gene was cloned
into a Pichia expression vector containing yeast alpha
mating factor. This secretory construct was tagged with
6xHis epitope to facilitate purification steps. To our know-
ledge, this is the first report on successful expression of
heterologous urate oxidase in P. pastoris.
Results
Preparation of urate oxidase expression cassette
The expression construct was prepared in order to provide
a high level expression of urate oxidase in P. pastoris. The
codon optimized A. flavus urate oxidase gene sequence
was synthesized commercially. The sequence alignment of
the A. flavus urate oxidase and its optimized form is
shown in Additional file 1. The synthesized gene segment
with the size of 956 bp was cut from pGH-UOX plasmid
and successfully cloned into XhoI/XbaI linearized pPIC-
ZαA. Restriction analysis (Figure 1) and DNA sequencing
(data not shown) of pPICZαA-UOX plasmid confirmed
the cloning procedures and correct orientation of insert
inside the vector.Figure 1 Restriction analysis of pPICZαA-UOX construct. A: Schematic
of pPICZαA-UOX plasmid. Lane 1: Size marker. Lane 2: Fragments created b
Lane 3: Fragments created by BamHI/HindIII digestion of the construct with
by XbaI/XhoI digestion. Two fragments of 3515 and 951 bp are present. LanTransformation of P. pastoris and screening of multi copy
transformants
P. pastoris GS115 strain was transformed with pPICZαA-
UOX plasmid using electroporation method and trans-
formants were grown on media containing 200 μg/ml of
Zeocin™. In an attempt to further enhancement of pro-
tein production levels, we isolated multicopy integrants
using the Zeocin screening procedure. The result of
PCR on genomic DNA extracted from well grown col-
onies on Zeocin concentration of 1600 μg/ml showed
that pPICZαA-UOX expression cassette is inserted
successfully into the GS115 genome. The integration
of expression cassette in the genome was confirmed
again by PCR using 5′ and 3′ AOX primers (Additional
file 2A).
Expression analysis of urate oxidase
Expression of recombinant urate oxidase was induced by
methanol as described in Methods. RT-PCR analysis of
methanol induced transformant confirmed the expression
of urate oxidase at mRNA level (Additional file 2B).
In SDS-PAGE, the expressed band of urate oxidase
was clearly detected (Figure 2). Lanes 4 and 5 in Figure 2
show the expressed band of urate oxidase in both concen-
trated and native supernatants of GS115 positive transfor-
mant culture media after 4 days of induction. Lanes 1and
2 are the same as 4&5 but related to the empty vector
transformant.
Densitometry analysis on SDS-PAGE gels demonstrated
that the recombinant urate oxidase represents ~24% of
total protein in supernatant. This was equal to 37 mg/L of
supernatant (See Additional file 3).
In western blot analysis of cell-free supernatant using
anti-His antibody, a positive band of ~35 kD was detected.representation of pPICZαA-UOX construct map. B: Restriction mapping
y EcoRV/HindIII treatment. Two bands of 2602 and 1864 bp are seen.
size of 2788 and 1678 bp. Lane 4: The restriction fragments created
e 5: XbaI linearized construct with a size of 4466.
Figure 2 SDS-PAGE analysis of concentrated supernatants from positive transformant and the control. Lane 1: Concentrated supernatant
of empty vector transformant as negative control. Lane 2: Non-concentrated supernatant of empty vector transformant as negative control. Lane
3: Protein marker. Lane 4: Concentrated supernatant of GS115 positive transformant culture after 4 days of induction. Lane 5: Non-concentrated
supernatant of GS115 positive transformant culture after 4 days of induction. Black arrow shows the expressed urate oxidase.
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transformant culture supernatant and lanes 2 and 3 indi-
cate negative and positive controls, respectively. Figure 3B
shows the result of western blot analysis using anti-
rasburicase polyclonal antibody. Lane 1 and 3 represent
the positive control (commercial rasburicase) and the
expressed uricase, respectively.
The His-tagged urate oxidase was purified and used in
activity assays (see Additional file 4).Urate oxidase activity
The enzyme activity in concentrated supernatants or
purified fractions was determined by a spectrophotometric
assay as described in Methods. The urate oxidase activity
in cell free supernatant was calculated as 0.43 U/ml of
96 h cultures. The activity of purified enzyme was cal-
culated as 11.6U/mg.Discussion
High cost is the major disadvantage of treatment by a
variety of recombinant pharmaceutics including urate
oxidase. Hence, the development of more efficient ex-
pression systems to produce large amounts of recombin-
ant proteins very economically is under focus (Cheng
Hou et al. 2011).
Eukaryotic cells such as S. cerevisiae, H. polymorpha
and P. pastoris are remarkable hosts for the large scale
expression of recombinant products, and the superiority
of P. pastoris in the quality and quantity of expressed pro-
teins has been emphasized in various studies (Cereghino
and Cregg 2006). As an example, when the horseradish
peroxidase encoding gene expressed in saccharomyces
cerevisiae was transferred into P. pastoris, the expressed
enzyme activity increased 5 to 6 times (Morawski et al.
2000). In a review by Valero, a prokaryotic system like
Escherichia coli and some eukaryotic systems such as
Figure 3 Western blot analysis on supernatant of GS115 transformant culture media. A: Western blotting using anti-His tag antibody. Lane
1: Concentrated supernatant of GS115 positive transformant culture media after 4 days of induction. Lane 2: Concentrated supernatant of empty
vector transformant. Lane 3: 18 kDa his-tagged protein as a positive control. B: Western blotting using anti-rasburacase antibody. Lane 1: positive
control (commercial rasburicase), Lane 2: Negative control (Concentrated supernatant of empty vector transformant) and Lane3 Concentrated
supernatant of GS115 positive transformant. Black arrows show the expressed urate oxidase.
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in terms of productivity and downstream processing facil-
ities for lipase expression (Valero 2012). According to this
review, the P. pastoris expression system has been shown
to be the most promising system.
In the majority of published reports, the E. coli expres-
sion system has been used for the recombinant produc-
tion of urate oxidase (Legoux et al. 1992); (Nakagawa
et al. 1995) (Li et al. 2006). The maximum expression
obtained in E. coli has been 238 mg/L which is obviously
less than the expression quantities in yeasts (Li et al.
2006). Usually in prokaryotic expression systems initiat-
ing methionine remains in enzyme structure and affects
both the constancy and activity of the enzyme and also
the therapeutical applications will fail (Valero 2012).
In registered patent of Sanofi-Aventis Company, the
amount of urate oxidase expression in S. cerevisiae cell
lysate is 0.255 mg/ml which is not high enough (Caput
et al. 1995). Furthermore, as a result of high level of
impurities (3 mg/ml) in the mixture of cell lysate, costly
purification steps would be essential.
According to Chen et al., the only appropriate amount
of urate oxidase expression in yeast has been achieved in
H. polymorpha (Chen et al. 2008). In their report, the
Candida utilis urate oxidase was expressed by H. poly-
morpha and α-MF signal sequence of S. cerevisiae was
used to secret the protein. The preliminary expression
level in shake flask was 0.3 U/ml of culture medium. Fur-
ther optimization of the fermentation process resulted in
increased levels up to 174 times, giving an extracellularexpression level of 2.1 g/L and an intracellular expression
of 2.4 g/L. However, the higher level of intracellular pro-
tein compared to the extracellular protein implicates a
problem during the secretion of the recombinant protein
into the culture medium. In a recent study by Dmytruk
and colleagues, the recombinant urate oxidase activity
expressed in H. polymorpha showed lower activity com-
pared to the commercially available enzyme (Dmytruk
et al. 2011).
In our study, the amount of expressed urate oxidase in
P. pastoris is about 24.2% of total supernatant proteins,
while the produced urate oxidase in S. cerevisiae is 8.5%
of the total lysate proteins. Although the expression level
of 0.4 U/ml in shaking flask is promising, however more
optimization is required. The activity of purified recom-
binant urate oxidase was 11.6 U/mg which is less than
commercially available enzyme (18.2 U/mg). This can be
due to cultivation techniques and purification conditions
which are reported to be important in productivity, stabil-
ity and activity of the recombinant proteins (Macauley-
Patrick et al. 2005). The higher expression and activity of
urate oxidase by selecting the more efficient colonies and
the optimization of the fermentation and purification con-
ditions can be expected.
Conclusion
The presented data show the ability of P. Pastoris in the
expression of active recombinant urate oxidase (UOX). The
Recombinant production of the enzyme in this methylo-
trophic yeast may be translated into the development of
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of UOX biosimilars.
Methods
Strains, reagents and culture media
Pichia pastoris (Invitrogen) strain GS115 as the expres-
sion host and pPICZαA (Invitrogen) as the expression
vector were used for heterologous protein expression.
Escherichia coli strain Top10 (Invitrogen) cells were
used in DNA recombinant procedures. Buffered complex
medium, containing glycerol (BMGY; Invitrogen) was
used for growing the cells before induction and buffered
complex medium containing methanol (BMMY; Invitro-
gen) was used as induction medium. Restriction enzymes
were purchased from Fermentase. Anti-His antibody for
detection of recombinant histidine-tagged urate oxidase
was purchased from Roche Applied Science. Other re-
agents were obtained from standard commercial sources.
Construction of expression vector
The A. flavus urate oxidase gene sequence was obtained
from database and codon optimized according to the
P. pastoris codon usage. To express urate oxidase protein
with a native N terminus, the XhoI site at base pairs
1184–1189 of the expression vector pPICZαA (Invitrogen
easy select Pichia Expression kit) was used to clone the
gene flush with the Kex2 cleavage site. So this sequence
(CTCGAGAAAAGAGAGGCTGAAGCT) was included
in upstream of the urate oxidase gene sequence and poly-
histidine (6X) tag sequence was added to the downstream
of urate oxidase gene before stop codon. The modified
synthetic gene (GeneRayBiotech, Shanghai) was supplied
as a circularized plasmid, pGH–UOX, containing all the
necessary restriction sites for directional cloning into
pPICZαA. The urate oxidase gene was cut out from
pGH-UOX using XhoI/XbaI double digestion and sub-
sequently cloned into XhoI/XbaI site of pPICZαA. The
final construct was called pPICZαA-UOX and confirmed
by restriction analysis and sequencing.
Transformation of GS115 cells
Ten micrograms of SacI linearized pPICZαA-UOX plas-
mid was used in transformation of GS115 cells using an
electroporation method provided by the manufacturer
(Invitrogen easy select Pichia Expression Kit). The cells
were washed in two successive steps with sterilized
water and 1 M sorbitol based on manufacturer protocol.
Following the electroporation step, the transformants
were selected on YPDS agar medium containing Zeocin
(200 μg/ml). Increasing concentrations of Zeocin™ were
used to isolate multi-copy transformants. This screening
procedure was carried out by re-plating the grown col-
onies on various increasing concentrations of Zeocin from
400 μg/ml to 1600 μg/ml. Genomic DNA of transformantswas extracted and the presence of expression cassette was
confirmed by urate oxidase specific primers: UOX_f (5′-
TCCGCAGTTAAAGCTGC-3′) and UOX_r (5′-CAATT
TAGACTTCAGAGAGG-3′). The second confirmatory
PCR was carried out with primers spanning the AOX1 ele-
ments (AOX_f: 5′-GACTGGTTCCAATTGACAAGC-3′
and AOX_r: 5′-GAAATGGCATTCTGACATCC-3′).
The expression of recombinant urate oxidase in GS115
strain
A single colony of GS115 transformant was grown in
50 ml of BMGY at 30°C in a shaking incubator (250 rpm).
The cells (OD600 = 4) were harvested and resuspended
in 200 ml of BMMY in a 1 L triple side baffled flask
(OD600 = 1.0) to induce expression at 30°C. Absolute
methanol was added to a final concentration of 0.5%
every 24 h to maintain the induction.
RNA isolation and cDNA synthesis
Two single colonies of GS115 transformed with pPIC-
ZαA and pPICZαA-UOX vectors were grown under
methanol induction as described. Total RNA was iso-
lated using the RNeasy Plus mini kit (Qiagen) and cDNA
was synthesized from RNA using RevertAid First Strand
cDNA Synthesis Kit (Fermentase) according to the manu-
facturer’s instructions. PCR reaction using UOX primers
was done on cDNA of an empty vector transformed
GS115 strain as negative control and pPICZαA-UOX
transformed strain to detect any urate oxidase transcripts.
SDS-PAGE, western blotting and purification
Supernatant of BMMY expression culture medium was
harvested and then was concentrated ten to hundred
fold using an Amicon stirred ultrafiltration cell 8400
equipped with a 10 KDa cut off filter (Millipore, USA).
The electrophoretic separation of proteins was carried
out in a 12% polyacrylamide gel and western blotting
was performed according to the standard methods. The
concentrated supernatant of GS115 transformed with
empty vector (pPICZαA) was used as the negative con-
trol in both tests. A rabbit polyclonal antibody against
commercial urate oxidase was prepared using the standard
procedures (Cooper and Paterson 2008). This antibody
was used in confirmatory western blot analysis. Anti-His
antibody was also used in western blot analyses to con-
firm His-tagged urate oxidase expression. An 18 kDa
His-tagged protein was used as a positive control. The
recombinant His-tagged urate oxidase was purified
from the supernatants by affinity chromatography using
an Ni-NTA purification system (Quiagen, USA) Equili-
bration of Ni-NTA column, washing of weakly bound
proteins and elution of the purified protein were per-
formed using 10 mM, 20 mM and 300 mM imidazole
buffer, respectively. The Bradford assay was used in
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was done using Quantity One software to measure the
expression level of secreted urate oxidase.Urate oxidase assay
The urate oxidase activity was determined using a modi-
fied urate oxidase/phenol/4-aminoantipyrine colorimetric
assay (Klose et al. 1987)). Briefly, uric acid can be specific-
ally converted to allantoin and hydrogen peroxide by urate
oxidase. Subsequently, the resulting hydrogen peroxidase
reacts with 4-aminoantipyrine in the presence of peroxid-
ase to generate a pink color product with an optimum ab-
sorption in 505 nm. The intensity of the produced color is
directly proportional to urate oxidase activity.
300 μl of the concentrated cell free supernatant or
purified urate oxidase fraction was added to a reaction
mixture containing 100 μl uric acid solution (6 mM in
borate buffer, pH 8.6), 50 μl horseradish peroxidase
(15 U/ml in phosphate buffer), 1.5 μl phenol and 150 μl
4-aminoantipyrine (30 mM). The reaction was incubated
at 37°C for 30 minutes.
The increasing concentrations of commercial urate oxi-
dase (Fasturtec: Sanofi Aventis, 2.7 U/ml) were added to
assay mixtures as above and the corresponding optical
densities were measured to construct the standard curve.
The enzyme activity of samples was calculated using this
standard curve (Additional file 5).Additional files
Additional file 1: A Sequence alignment of A. flavus urate oxidase
and its optimized form. The asterisks indicate identical bases.
Additional file 2: PCR and RT-PCR analysis of UOX transformant. A.
Genomic amplification of urate oxidase expression unit using AOX
specific primers. Lane 1: PCR product amplified from a pPICZαA-UOX
positive Pichia transformant (~1.5 kb), Lane 2: Positive control (pPICZαA-UOX
plasmid), Lane 3: Negative control (genomic DNA from an empty vector
transformant), Lane 4: Size marker. B: RT-PCR analysis of pPICZαA-UOX
positive transformant using UOX primers. Lane 1: An approximately
750 bp amplified fragment from a positive Pichia transformant, Lane 2:
No amplification in negative control (empty vector transformant), Lane
3: Positive control (pPICZαA-UOX plasmid), Lane 4 : The same as 1 but
with 1:10 dilution of cDNA, Lane 5: PCR result on RNA (No amplification)
and Lane 6: Size marker.
Additional file 3: Densitometry analysis of proteins on SDS-PAGE of
UOX positive transformant culture supernatant. Band 18 (expressed
urate oxidase) constitutes ~24% of total proteins.
Additional file 4: SDS –PAGE analysis of Purified His-tagged urate
oxidase. Gel was stained with coomassie blue. Lane1: Positive control,
Lane2: Size marker and Lane 3: purified protein.
Additional file 5: A standard curve used in urate oxidase activity
assay. As described in methods, the different volumes of standard stock
(Rasburicase, 0.1 mg/ml, 2.7 U/ml) were added to the reaction mixtures
and optical densities were measured at 505 nm.Competing interests
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